Publications

Budinsky R, Urban J, Rowlands JC. 2011. An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor nuclear translocator gene. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Ceder R, Merne M, Nilsson J-A, Staab C, Höög J-O, Thompson CM, Grafström RC. Toxicogenomic profiling of formaldehyde-exposed normal and transformed human oral keratinocytes. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Fitzgerald L, Burkhalter B, Urban J, Staskal D, Harris M, Haws L. VOC serum levels in the general U.S. population: An analysis of the 2003-2004 NHANES dataset. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011

Haws L, Proctor D, Thompson C, Harris M. Research plan to fill data gaps in the mode of action for cancer risk assessment of hexavalent chromium in drinking water. Presented at  Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Henderson RG, Cappellini D, Seilkop S, Oller A, Bates H. Bioaccessibility-based read-across assessment of nickel compounds for oral systemic toxicity. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Kim S, Thompson CM, Kopec AK, Harris MA, Zacharewski TR. Comparison of basal and CrVI-mediated solute carrier gene expression in rodent duodenal epithelium. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Proctor D, Haws L, Thompson C, Harris M. 2011. Use of mode of action and pharmacokinetics to inform the cancer risk assessment of ingested Cr(VI): A case study. Presented at the Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Staskal-Wikoff D, Budinsky R, Rowlands JC. Single nucleotide polymorphisms in the human aryl hydrocarbon receptor interacting protein (AIP) gene from six ethnic populations. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Urban J, Fitzgerald L, Burkhalter B, Staskal D, Harris M, Haws L. BTEX serum levels in the general U.S. population: An analysis of 2003-2004 NHANES dataset. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Thompson CM, Grafström RC. 2011. Considerations for the implausibility of leukemia induction by formaldehyde. Toxicol Sci 120(1):230-232; doi: 10.1093/toxsci/kfq340. PMID: 21059796.

Hale AC, Tries MA. 2011. Determination of ²³⁹Pu airborne concentration alpha correction factor for a zinc sulfide detector via ambient ²²²Rn progeny air sampling. Health Phys 100(2):201–209; doi: 10.1097/HP.0b013e3181e928a7. PMID: 21399436.

Beyer BK, Chernoff N, Danielsson BR, Davis-Bruno K, Harrouk W, Hood RD, Janer G,…, Rogers JM, Scialli AR. 2011. Maternal toxicity and its impact on study design and data interpretation. Birth Defects Res B 92(1):36–51; doi: 10.1002/bdrb.20281. PMID: 21312321.

Hinerman J, Herr A. Determining the mechanism of activation of glycoprotein VI. Poster presented to the Ohio Valley Crystallographic Symposium Meeting, Cleveland, OH, November 2011.

Hart BR, Mishra PK, Lintner RE, Hinerman JM, Herr AB, Blumenthal RM. 2011. Recognition of DNA by the helix-turn-helix global regulatory protein Lrp is modulated by the amino terminus. J Bacteriol 193(15):3794–3803; doi: 10.1128/jb.00191-11. PMID: 21642464.

Proctor D, Meek B. Using mode of action data to guide quantitative cancer risk assessment: A case study of hexavalent chromium in drinking water. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Shum M, Kelsh MA, Sheppard AR, Zhao K. 2011. An evaluation of self-reported mobile phone use compared to billing records among a group of engineers and scientists. Bioelectromagnetics 32(1):37–48; doi: 10.1002/bem.20613. PMID: 20857456.

Thompson CM, Haws LC, Harris MA, Gatto NM, Proctor DM. 2011. Application of the U.S. EPA mode of action framework for purposes of guiding future research: A case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci 119(1):20-40; doi: 10.1093/toxsci/kfq320. PMID: 20947717.

Yong M, Kuehn C, Kelsh M, Mitchell M, et al. Associations between platelet count and survival and disease progression in thrombocytopenic patients with myelodysplastic syndromes. Presented at the American Society of Hematology, Orlando, FL, December 2010.

Daston GP, Chapin R, Scialli AR, Piersma AH, Carney EW, Rogers JM, Friedman JM. 2010. A different approach to validating screening assays for developmental toxicity. Birth Defects Res B 89(6):526–530. doi: 10.1002/bdrb.20276. PMID: 21086491.

Robison TW. Genotoxic impurity guidance – Current experiences, FDA perspective. USP Annual Meeting, New Orleans, LA, December 2010.